Views: 0 Author: Editor Public Time: 2022-09-13 Origin: Situs
In Augusti, in coid, in multis locis in multis locis. Lanzhou Petrochemical Company Tulit inceptum ad implere responsabilitatem magnam statum-possessores conatibus, et auctus productio et sit amet RP260, in pestilentia praeventionis medicinae materiales. In August, a totalis 4,852.75 tons RP260 medical materia fuit productum, quod occurrit productio demanda customers ad maximam quatenus.
RP260 Medical Material produci by Lanzhou Petrochemical Company est pelagus rudis materia ad pesticulum medicinae cogitationes. In the face of the rebounding COVID-19 epidemic, Lanzhou Petrochemical strictly implemented the epidemic prevention and control policies and measures, implemented the two-point and one-line epidemic prevention and control requirements of 'unit-place of residence', compacted the 'four-party' responsibilities of territories, departments, units and individuals, and killed offices, production sites, onerariam vehicles, acquirendi materiae, etc quotidie. Aliena curatores sunt secundum ordinem ad ordinationes 'qui probat et qui utitur sit reus ', quod efficaciter curbed de Covi-XIX pestilentia. On the other hand, increase the production and shipment of RP260, timely adjust the production plan of RP260 according to market demand, increase the output of RP260, carefully organize production, optimize the production plan and workflow, adjust and confirm 14 control measures in eight aspects according to the special control plan of 'one product, one policy', and constantly improve and refine the conversion plan, carefully operate and strengthen the control of the production Processus sic cognoscere firmum et altum cedat RP260.
